Sandoz Cuts Emissions 15% as Climate Targets Get Validated

A major pharmaceutical company just earned independent approval for its ambitious plan to slash greenhouse gas emissions by nearly half in the next five years.

Sandoz, a global medicine manufacturer, received validation from the Science Based Targets initiative for its climate goals. SBTi is an independent organization that helps companies create credible plans to fight climate change using real science.

The company committed to cutting emissions from its own operations by 42% by 2030 and 63% by 2035, compared to 2024 levels. Sandoz also pledged to ensure that 79% of its suppliers adopt science-based climate targets by 2030, spreading the impact far beyond its own walls.

"Our actions are critical to limiting our impact on the environment while delivering real commercial benefits," said Kate Ahern, head of sustainability at Sandoz. The company sees sustainability as essential to its mission of making medicines accessible to patients worldwide.

Sandoz isn't just making promises for the future. Between 2023 and 2025, the company already reduced its total emissions by 3% and cut emissions intensity by 15%.

The Ripple Effect

The company's sustainability blueprint shows how large corporations can turn climate action into business value. Sandoz is improving energy efficiency across facilities, switching to renewable energy sources, and redesigning packaging to reduce waste.

The pharmaceutical giant is also overhauling its logistics to cut transportation emissions and partnering with suppliers to develop sustainable solutions together. These changes don't just help the planet; they also reduce costs and meet growing customer demand for environmentally responsible products.

By requiring suppliers to adopt science-based targets, Sandoz is creating a ripple effect throughout the pharmaceutical supply chain. When nearly 80% of a major company's suppliers commit to climate action, the impact multiplies across industries and borders.

Independent validation from SBTi gives teeth to corporate climate commitments, separating real action from greenwashing. It confirms that Sandoz's targets align with what scientists say is necessary to prevent the worst impacts of climate change.

When major pharmaceutical companies prove that sustainability and business success can go hand in hand, they light the path for others to follow.